https://www.selleckchem.com/pr....oducts/lonidamine.ht
Two patients had BCG-itis and four patients had "BCG-osis". Survival rate was 75% after successful disease management with antibiotics, anti-tuberculous agents and recombinant IFN-γ. It was concluded that MSMD must be differentiated from different forms of primary immunodeficiencies, so clinicians should be aware of MSMD especially in patients with BCG vaccine complications and non-tuberculous mycobacterial infection. It was concluded that MSMD must be differentiated from different forms of primary immunodeficiencies, so clinicians s
Beğen
Yorum Yap
Paylaş
